Worst performer was SBTX:SkinBioTherapeutics which is particularly frustrating as I had a sell order in for 18.75p and if I'd just gone online and sold them I could have done so for 18.5p quite easily. This week they dropped 18% to a bid price of 15.5p so I could have banked my profits and bought more back. I knew this would happen, as it's happened with OPTI:Optibiotix all along. Unfortunately recent experience has made me wary of this tactic as I shall cover later.
CAML:Central Asia Metals got hammered along with the rest of the metals sector and dropped 9%. This has now fallen from around 340p to 268p over the last few months despite being in a far, far better position. I'm expecting a rapid rise when the next trading update comes out and the new operation starts being reflected in the balance sheet. I would be accumulating if I had the cash to get the holding back up around the 10% of portfolio mark.
MMX:Minds + Machines was very much a punt to try and get some short term profit, as I felt the massive drop was unjustified. It's now looking like less of a short term investment and again demonstrates when I attempt anything vaguely like trading it doesn't seem to work. These fell 5% this week and are 14% down on what was already a very depressed price.
OPTI:Optibiotix dropped 4%, but as mentioned above that 3p had a devastating effect on the week. I keep saying one day these will break out, but after nearly 3 years it's getting a tad tiresome. It will happen though, and will be all the sweeter for the wait and the chance to accumulate so many shares.
There was some good news to balance the bad. IKA:Ilika has been completely rubbish since I bought them, but after the announcement of a big grant for two projects to research using their solid state batteries in vehicles, the share price climbed 7% and is now only 60% down from when I bought them. The first project is with Honda, Ricardo, the Centre for Process Innovation ("CPI") and University College London and the second is with McLaren, A123 Systems and the University of Warwick. These are encouraging partners, but at the moment IKA:Ilika is a research organisation and not a commercial business.
N4P:N4 Pharma leapt 12% this week and is now up 18% and making £227 potential profit. There are many encouraging signs for this one, and revenue may not be too far away.
VRS:Versarien scores Share of the Week for the second week in a row, climbing 18% to go 79% up with a paper profit of £3,392 which overtakes CAML:Central Asia Metals and makes it Star Share. This relentless rise is utterly brilliant, but I still can't get the frustration out of my head that I sold 25% of my holding at 94p and lost out about £500 I could have got if I held until now. Given my holding has now hit my 10% limit, I would have sold some but in a more controlled manner. I was just so convinced it would behave the same as OPTI:Optibiotix and slump back to 70p when the traders started playing around. Given VRS:Versarien is further away from revenue than OPTI:Optibiotix, it's surprising that the share price has done what the OPTI:Optibiotix price just refuses to do and broken the 100p barrier. If OPTI:Optibiotix could just do what VRS:Versarien has done, then I'd be sat on £38,000 paper profit. Oh the agony!!
It's around 20 weeks that the portfolio has been in the red, apart from the brief blip near week 136. The trend line is still up, but getting more shallow.
The ISA and share portfolios looks like this
| Weekly Change | |||
| Cash | £7.38 | +£0 | |
| Portfolio cost | £52,236.06 | +£0 | |
| Portfolio sell value (bid price - commission) | £47,510.47 | (-9%) | -£846.87 |
| Potential profits | £3,506.58 | +£452.27 | |
| Yr 3 Dividends | £44.15 | +£0 | |
| Yr 3 Profit from sales | £8,387.31 | +£0 | |
| Yr 3 Average monthly cash profit | £808.31 | (18.6%) | -£18.37 |
| Total Dividends | £1,223.20 | +£0 | |
| Total Profit from sales | £15,099.81 | +£0 | |
| Average monthly cash profit | £470.56 | (10.8%) | -£3.18 |
| (Sold stocks profit + Dividends - Fees / Months) |
Potential profits are actually up thanks to the big rise in VRS:Versarien and the fact that most of the other big drops were deepening losses. Not much else happening really.
Still a very big gap to fill and a downward trend line.
The SIPP looks like this after week 133
| Weekly Change | |||
| Cash | £30.28 | +£0 | |
| Portfolio cost | £27,893.76 | +£0 | |
| Portfolio sell value (bid price - commission) | £28,003.12 | (0.4%) | -£845.74 |
| Potential profits | £2,158.01 | -£533.05 | |
| Yr 3 Dividends | £292.57 | +£0 | |
| Yr 3 Profit from sales | £1,619.73 | +£0 | |
| Yr 3 Average monthly cash profit | £274.79 | (11.8%) | -£9.81 |
| Total Dividends | £1,208.67 | +£0 | |
| Total Profit from sales | £10,544.92 | +£0 | |
| Average monthly cash profit | £375.75 | (16.2%) | -£2.84 |
| (Sold stocks profit + Dividends - Fees / Months) |
Potential profits whacked by the big drop in CAML:Central Asia Metals, and the drop would have been worse if N4P:N4 Pharma hadn't done well. At this rate I'll be able to keep going without a sell for over a year and still be above my 10% return target.
Only just in the black. This account very rarely drops into the red so I really hope there's a reversal next week. The trend line is very positive though, and I must remember that I've banked quite a lot of profit.
I received a message from my broker saying that my entitlement share offer from TLOU:Tlou Energy will be activated next week. I've loaded £220 into my ISA which will be enough to cover my entitlement of 3,498 shares as it's one for every six owned. The price is 5.75p which is a bargain, especially as I paid 10p for my existing shares thinking the sudden drop from 16p was over-done. Looks like I called that one wrong! I'm still confident these will get back to 16p shortly, just based on the huge reserves that have already been confirmed. If the power plant is also agreed, then heaven knows where they could end up. I just wish I'd waited until now to re-invest, but calling the bottom is just a matter of luck.
There are a few pending announcements that I'm hoping will come in next week. OPTI:Optibiotix are due to launch their web shop soon, so I'm hoping that will come very soon and get the share price heading up again. KIBO:Kibo Mining must surely be close to signing the Power Purchase Agreement as that's been dragging on for ages.
Having said that, MTFB:Motif Bio announced the completion of their NDA submission last week, and the share price managed to stay completely flat. Given that it was the announcement of a delay in the submission which caused the share price to collapse, how the hell does it go nowhere when the reverse announcement is made? At least these are still pretty much at the price I paid for them so my 3% loss is just spread and commission.
I toyed with selling all my VRS:Versarien shares as I'm sure they have gone way past their true value, but after my 94p sale being such a disaster I can't bring myself to do it. In fact I desperately want to buy my shares back, and more. They are probably the world leaders in the most groundbreaking new tech that's been discovered for decades, and people are talking about graphene as being a new industrial revolution. There doesn't seem to be anything that can't be enhanced in some way by it. If VRS:Versarien can protect their IP and the competition struggle to manufacture the true few-layer graphene called nanene, then this could easily be a world beater, just like OPTI:Optibiotix!
I sometimes get a bit down after a week like this, however I had a quick tot-up of my average monthly realised profits and was quite shocked to see it is now £846. I'm sure last time I looked it was less than £700. That's a pretty stonking return, and I make it around 18% p/a based on the original £55K I invested. My weekly calculations are all based on the current portfolio value, so as the value increases from re-investment, the harder it gets to keep at the 10% target. This is good, as it means I have to make more every year to keep up. It doesn't seem long ago that I was getting the odd £25 premium bond prize each month and maybe £10 interest from my cash ISA. That thought will always see me through the more troubling weeks...
No comments:
Post a Comment